Combined Inhibition of PI3K and mTOR Exerts Synergistic Antiproliferative Effect, but Diminishes Differentiative Properties of Rapamycin in Acute Myeloid Leukemia Cells

Author： Mise Josko  

Publisher： Springer Publishing Company

ISSN： 1219-4956

Source： Pathology & Oncology Research, Vol.17, Iss.3, 2011-09, pp. : 645-656

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The microtubule depolymerizing agent CYT997 effectively kills acute myeloid leukemia cells via activation of caspases and inhibition of PI3K/Akt/mTOR pathway proteins

By            

Experimental and Therapeutic Medicine, Vol. 6, Iss. 2, 2013-01 ,pp. : 299-304

Spandidos Publications

Access to resources Recommend Favorite

BxPC3 pancreatic cancer cells express a truncated Smad4 protein upon PI3K and mTOR inhibition

By      

Oncology Letters, Vol. 7, Iss. 4, 2014-01 ,pp. : 1165-1168

Spandidos Publications

Access to resources Recommend Favorite

A Novel Quinoline Based Second-generation mTOR Inhibitor that Induces Apoptosis and Disrupts PI3K-Akt-mTOR Signaling in Human Leukemia HL-60 Cells

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 10, 2015-12 ,pp. : 1297-1304

Bentham Science Publishers

Access to resources Recommend Favorite

Synergistic effect of ginsenoside Rg3 with verapamil on the modulation of multidrug resistance in human acute myeloid leukemia cells

By Kim Sung Su   Seong Sin   Kim Sung Young  

Oncology Letters, Vol. 7, Iss. 4, 2014-04 ,pp. : 1265-1269

Spandidos Publications

Access to resources Recommend Favorite

2.1.3. Pan-PI3K/mTOR Inhibition

By  

International Journal of Cancer Research and Prevention, Vol. , Iss. , 2017-01 ,pp. : 77-76

Nova Science Publishers, Inc.

Access to resources Recommend Favorite